1NIELSEN A G, NIELSEN R B, RIIS A H,et al. The impact of sta- tin use on pneumonia risk and outcome: a combined population - based case- control and cohort study [J]. Crit Care, 2012,16 (4) : R122.
2TANG B M,ESLICK G D,CRAIG J C,et al. Accuracy of procalci- tonin for sepsis diagnosis in critically ill patients: systematic review and meta- analysis[J], lancet Infect Dis,2007,7(3) :210 -217.
3陆在英,钟南山.内科学[M].北京:人民卫生出版社,2011:17-21.
4DELLINGER R P, LEVY M M, CARLET J M, et al. Surviving Sepsis Campaign: international guidelines for management of se- vere sepsis and septic shock: 2008 [ J]. Crit Care Med,2008,36 ( 1 ) :296 -327.
5SUBERVIOLA B, CASTELLANOS - ORTEGA A, GONZALEZ - CASTRO A, et al. Prognostic value of procalcitonin, C -reactive protein and leukocytes in septic shock[ J]. Med Intensiva,2012,36 (3) :177 -184.
6KASAMATSU Y, YAMAGUCHI T, KAWAGUCHI T,et al. Use- fulness of a semi - quantitative procalcitonin test and the A - DROP Japanese prognostic scale for predicting mortality among a- dults hospitalized with community-acquired pneumonia[J]. Re- spirology,2012,17 (2) :330 -336.
7S1TYER T, SCHMIDT M, SCHNEIDER S,et al. Differential diag- nosis of bacterial infection and inflammatory response in kidney dis- eases using procalcitonin [ J 1. J Nephrol,2002,15 (3) :297 - 301.
